| Recruiting | Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment NCT07282093 | Ascentage Pharma Group Inc. | Phase 1 |
| Completed | Phase 1 Pharmacokinetic Study of Minoxidil SL Tablets NCT06679556 | Samson Clinical Operations Pty Ltd | Phase 1 |
| Completed | A Pharmacokinetic Study of Single Oral Doses of Six Different Vitamin C Product Forms NCT06471023 | dsm-firmenich Switzerland AG | N/A |
| Completed | Characterization of the Temporal Profile of the Anti-nociceptive Effect of Ketamine Bolus Measured With ANI NCT06344858 | Pontificia Universidad Catolica de Chile | — |
| Withdrawn | A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body NCT05938608 | University of Oxford | Phase 1 |
| Completed | A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects NCT06126562 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |
| Completed | Clinical Study to Compare the Effect of an Oral Rehydration Solution on the Rate of Absorption of Functional I NCT06524674 | Liquid I.V. | N/A |
| Completed | Evaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to NCT06378125 | University Hospital Schleswig-Holstein | Phase 1 |
| Terminated | Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects NCT04080895 | University of Oxford | Phase 1 |
| Not Yet Recruiting | Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICU NCT05367011 | Poitiers University Hospital | — |
| Completed | F573 Ia Clinical Trial NCT04820049 | Beijing Continent Pharmaceutical Co, Ltd. | Phase 1 |
| Completed | Safety and Pharmacokinetics of Oral Controlled-ileocolonic-release Nicotinamide (CICR-NAM) NCT05258474 | University Hospital Schleswig-Holstein | Phase 1 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Femal NCT04531150 | Inversago Pharma Inc. | Phase 1 |
| Completed | A Pharmacokinetic Study of PLENVU® in Healthy Subjects NCT03437265 | Norgine | Phase 1 |
| Unknown | Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral NCT04735913 | Zhongnan Hospital | EARLY_Phase 1 |
| Unknown | A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneou NCT04326881 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248 NCT04617509 | Gesynta Pharma AB | Phase 1 |
| Completed | Clinical Trial on Pharmacokinetic and Tolerability of AP701 NCT04708795 | CannaXan GmbH | Phase 1 |
| Completed | Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Inf NCT04350502 | Centre Hospitalier Universitaire, Amiens | N/A |
| Completed | Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT NCT04959110 | Chulalongkorn University | N/A |
| Unknown | Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants. NCT03714568 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |
| Completed | Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation NCT03076151 | University Hospital, Limoges | Phase 4 |
| Completed | Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients NCT03344627 | Mahidol University | N/A |
| Terminated | Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants NCT03059511 | University Children's Hospital, Zurich | Phase 1 |
| Terminated | Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects NCT02696954 | University of Oxford | Phase 1 / Phase 2 |
| Completed | To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration NCT03011996 | HK inno.N Corporation | Phase 1 |
| Completed | Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy NCT03958123 | Tris Pharma, Inc. | Phase 1 |
| Completed | A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol NCT03882762 | Tris Pharma, Inc. | Phase 1 |
| Completed | A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleratio NCT01091532 | Pfizer | Phase 1 |
| Completed | Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Su NCT01082796 | Chinese Academy of Sciences | N/A |
| Completed | Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers NCT00743912 | Bausch Health Americas, Inc. | Phase 1 |
| Completed | Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-adm NCT00681395 | AstraZeneca | Phase 1 |
| Completed | Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alon NCT00745264 | IDEA AG | Phase 1 |
| Completed | Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol) NCT03979989 | Grünenthal GmbH | Phase 1 |
| Completed | Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and NCT03951987 | Grünenthal GmbH | Phase 1 |
| Completed | Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healt NCT03951402 | Grünenthal GmbH | Phase 1 |